Chapter PDF
Literatur
American Thoracic Society (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152:S77–S120
Anthonisen NR, Connett JE, Kiley JP et al. (1994) Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Heath Study. JAMA 272:1539–1541
Anthonisen NR, Manfreda J, Warren CPW (1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106:196–204
Barnes P, Godfrey S (1997) Chronic obstructive pulmonary disease. Martin Dunitz, London
Barnes PJ (2000) Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161:342–344
British Thoracic Society (1997) Guidelines for the management of chronic obstructive pulmonary disease. Thorax 52:S1–S28
Calverley PMA (2000) Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161:341–344
Canadian Thoracic Society Workshop Group (1992) Guidelines for the assessment and management of chronic obstructive pulmonary disease. Can Med Assoc J 147:420–428
Davies L, Angus RM, Calverley PMA (1999) Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 354:456–460
Demeester J, Smits JMA, Persijn GG, Haverich A (1999) Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration. J Heart Lung Transplant 18:563–571
Deutsche Gesellschaft für Pneumologie (1993) Empfehlungen zur Sauerstoff-Langzeit-Therapie bei schwerer chronischer Hyoxämie. Pneumologie 47:2–4
Fabbri LM, Caramori G, Beghe B et al. (1998) Chronic obstructive pulmonary disease international guidelines. Curr Opin Pulm Med 4:76–84
Fletcher C, Peto R (1977) The natural history of chronic airway obstruction. Br Med J 1:1645–1648
Gehring S, Rabenau H, Schneider W, Zielen S (1996) Adenovirusinfektionen als Ursache schwerer pulmonaler Erkrankungen im Kindesalter. Pädiatr Grenzgeb 34:325–330
Gillissen A, Buhl R, Kardos P et al. (2000) Inhalierbare Kortikosteroide in der Langzeittherapie der COPD. Stellungnahme eines Expertengremiums. Pneumologie 54: 256–262
Gillissen A, Tasci S, Ewig S, Schäfer H, Zielen S (2001) Sinn und Unsinn von Antitussiva. Internist 42:134–142
Irwing RS, Boulet L-P, Cloutier MM et al. (1998) Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American Chest Physicians. Chest 114:133s–181s
Jorenby DE, Leischow SJ, Niedes MA et al. (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340: 685–691
Kardos P, Gebhardt T, Decot E (1995) Chronisch persistierender Husten (CPH): Therapie. Pneumologie 49:47–54
Keenan SP, Brake D (1998) An evidence-based approach to noninvasive ventilation in acute respiratory failure. Crit Care Clin 14:359–372
Medical Research Council Working Party (1981) Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1:681–686
Niewoehner DE, Erbland ML, Deupree RH et al. (1999) Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 340:1941–1947
Nocturnal Oxygen Therapy Trial Group (1980) Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 93:391–398
Pauwels RA, Lofdahl C-G, Laitinen LA et al. (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 340:1948–1953
Peter G, Lepow M, McCracken GHE (1991) Ribavirin therapy of respiratory syncytial virus. Report of the committee of infectious diseases. Am Acad Pediatr 22:581–587
Petro W, Wettengel R, Worth H (1995) Empfehlungen zum strukturierten Patiententraining bei obstruktiven Atemwegserkrankungen. Pneumologie 49:455–460
Petty TL, Weinmann GG (1997) Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. JAMA 277:246–253
Schulz C, Riedel M, Gillissen A, Emslander HP (1998) Präoperative Identifizierung des pulmonalen Risikopatienten vor Lungenresektion. Atemw Lungenkrkh 24:205–214
Tarpy SP, Celli BR (1995) Long-term oxygen therapy. N Engl J Med 333:710–714
Vestbo J, Sørensen T, Langer P, Brix A, Torre P, Viskum K (1999) Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 355:1819–1823
Wettengel R, Berdel D, Cegla U et al. (1994) Empfehlungen der Deutschen Atemwegsliga zum Asthma Management bei Erwachsenen und bei Kindern. Med Klinik 89: 57–67
Wettengel R, Böhning W, Cegla U et al. (1995) Empfehlungen der Deutschen Atemwegsliga zur Behandlung von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem. Med Klinik 90: 3–7
Witt C, Schmidt W (2000) Risikofaktoren der COPD. In: Gillissen A (Hrsg) Die chronisch obstruktive Lungenerkrankung. Uni-Med Verlag, Bremen, S 32–43
World Health Organization (1961) WHO report of an expert committee: Definition and diagnosis of pulmonary disease with special reference to chronic bronchitis and emphysema. WHO Techn Rep Ser 213:14–19
Worth H, Adam D, Handrick W et al. (1997) Prophylaxe und Therapie von bronchiale Infektionen. Med Klinik 12: 699–704
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Heidelberg
About this chapter
Cite this chapter
Gillissen, A., Zielen, S. (2005). Bronchitis, Bronchiolitis und Lungenemphysem. In: Schölmerich, J., et al. Medizinische Therapie 2005|2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27385-9_105
Download citation
DOI: https://doi.org/10.1007/3-540-27385-9_105
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21226-3
Online ISBN: 978-3-540-27385-1
eBook Packages: Medicine (German Language)